Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan C Fuchs

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Surgical Research|September 13, 2005
Stressing out over survival: glutamine as an apoptotic modulatorBryan C Fuchs, Barrie P Bode
Seminars in Cancer Biology|May 27, 2005
Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?Bryan C Fuchs, Barrie P Bode
Frontiers in Oncology|July 26, 2018
New Directions in the Study and Treatment of Metastatic CancerByunghee Yoo, Bryan C Fuchs, Zdravka Medarova
Hepatobiliary Surgery and Nutrition|June 9, 2016
STAT3 is a key transcriptional regulator of cancer stem cell marker CD133 in HCCSarani Ghoshal, Bryan C Fuchs, Kenneth K Tanabe
Hepatology (Baltimore, Md.)|May 7, 2014
Reply: To PMID 24677197Bryan C Fuchs, Yujin Hoshida, Kenneth K Tanabe
Journal of Hepatology|October 4, 2011
Genomic risk of hepatitis C-related hepatocellular carcinomaYujin Hoshida, Bryan C Fuchs, Kenneth K Tanabe
Current Cancer Drug Targets|August 10, 2012
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesYujin Hoshida, Bryan C Fuchs, Kenneth K Tanabe
Cancer|April 18, 2018
Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapyDerek J Erstad, Bryan C Fuchs, Kenneth K Tanabe
The Journal of Clinical Investigation|January 3, 2019
Molecular imaging of fibrosis: recent advances and future directionsSydney B Montesi, Pauline Désogère, Bryan C Fuchs, et al.
Molecular & Cellular Oncology|June 16, 2017
The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancerDerek J Erstad, Andrew M Tager, Yujin Hoshida, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Surgical Research|September 13, 2005
Stressing out over survival: glutamine as an apoptotic modulatorBryan C Fuchs, Barrie P Bode
Seminars in Cancer Biology|May 27, 2005
Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?Bryan C Fuchs, Barrie P Bode
Frontiers in Oncology|July 26, 2018
New Directions in the Study and Treatment of Metastatic CancerByunghee Yoo, Bryan C Fuchs, Zdravka Medarova
Hepatobiliary Surgery and Nutrition|June 9, 2016
STAT3 is a key transcriptional regulator of cancer stem cell marker CD133 in HCCSarani Ghoshal, Bryan C Fuchs, Kenneth K Tanabe
Hepatology (Baltimore, Md.)|May 7, 2014
Reply: To PMID 24677197Bryan C Fuchs, Yujin Hoshida, Kenneth K Tanabe
Journal of Hepatology|October 4, 2011
Genomic risk of hepatitis C-related hepatocellular carcinomaYujin Hoshida, Bryan C Fuchs, Kenneth K Tanabe
Current Cancer Drug Targets|August 10, 2012
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesYujin Hoshida, Bryan C Fuchs, Kenneth K Tanabe
Cancer|April 18, 2018
Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapyDerek J Erstad, Bryan C Fuchs, Kenneth K Tanabe
The Journal of Clinical Investigation|January 3, 2019
Molecular imaging of fibrosis: recent advances and future directionsSydney B Montesi, Pauline Désogère, Bryan C Fuchs, et al.
Molecular & Cellular Oncology|June 16, 2017
The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancerDerek J Erstad, Andrew M Tager, Yujin Hoshida, et al.
Pageof 10